Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]





AZD 2281 - Olaparib - KU 0059436



CAS 763113-22-0 

C24H23FN4O3 MW 434.47

Purity: 99%






Ordering Information:


Cat. No. Axon 1464      Promotion      


1 x 5 mg / 75  $98

Promotion: 10 mg @ 100  $130

1 x 25 mg / 200  $260

Promotion: 50 mg @ 300  $390

Bulk on request


Send enquiry to:


Contact us for payment and tech support.


*fully QCed drug standard, COA/MSDS available


Biological Activity:


Highly potent, oral and selective inhibitor of poly(ADP-ribose) polymerase (PARP); with IC50 = 5 nM (PARP1) and 1 nM (PARP2). It blocks enzymes that repair DNA damage caused by cancer treatments such as radiation and drugs.


References: online        List of Publications Using Axon 1464


S Vasiliou et al. Olaparib. Drugs of the Future. 2009, 34(2), 101.


KA Menear et al. 4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. J. Med. Chem. 2008, 51(20), 65816591. [online]


S Rottenberg et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc. Nat. Acad. Sci. USA, 2008, 105(44), 1707984. [online]


T Hay et al. Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin. Cancer Res. 2009, 69(9), 3850. [online]


C Mitchell et al. Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells. Mol. Pharmacol. 2010, 78(5), 909-917. [online]



Chemical Name: 4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one


AZD 2281 - Olaparib | PARP inhibitor | Axon 1464 | AZD2281 from supplier Axon Medchem


Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis. 2014


Axon Ligands in the field:


3-AB | PARP inhibitor

ABT 888 | PARP inhibitor

AG 014699 | PARP inhibitor

AZD 2461 | PARP inhibitor

DR 2313 | PARP inhibitor

Iniparib | PARP inhibitor

KU 0058948 | PARP inhibitor

NU 1025 | PARP inhibitor

Olaparib | PARP inhibitor



Click Here To See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection